Ann: Change in substantial holding, page-8

Thanks for your clarification Bf. However I think validation of the many other devices will now fall within the remit of Mr Meng, and that's one of the prime reasons explaining why he wants to be part of this business. It's a credence issue from a tech person and with his depth of medical connections in China, let alone qualifications, it's my view this year will amount to a company maker. No doubt he will have a priority list for device approvals and put them in train at the speed of light compared to Dr Rob Phillips sustained efforts to break into this truly massive market

**nb: Your back of the napkin, numbers look Ok to me in terms of conservative revenue flow